Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Nonlethal transfusion associated graft-versus-host disease in a severe combined immunodeficient patient

Summary:

An X-linked severe combined immunodeficient (SCID) patient received a nonirradiated erythrocyte transfusion and developed transfusion-associated graft-versus-host disease (TAGVHD), which was controllable with high-dose corticosteroids. Haplo-identical SCT was performed, after a myeloablative conditioning regimen. At day +26, he developed GVHD. Chimerism studies revealed DNA of the erythrocyte transfusion donor (ETD) and recipient only. Because of early nonengraftment and the presence of alloreactive T cells of ETD origin, the patient was treated with an immunosuppressive conditioning regimen followed by a second SCT from the same donor. While tapering immunosuppression, he again developed mild GVHD, and DNA of ETD and bone marrow donor origin were both present. On cyclosporin, the ETD-DNA signal finally disappeared. High-resolution HLA typing revealed haplo-identity between BMD, ETD and the patient, which might have contributed to the relative mild course of the TAGVHD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Schroeder ML . Transfusion-associated graft-versus-host disease. Br J Haematol 2002; 117: 275–287.

    Article  Google Scholar 

  2. Orlin JB, Ellis MH . Transfusion-associated graft-versus-host disease. Curr Opin Hematol 1997; 4: 442–448.

    Article  CAS  Google Scholar 

  3. Friedman DF, Kwittken P, Cizman B et al. DNA-based HLA typing of nonhematopoietic tissue used to select the marrow transplant donor for successful treatment of transfusion-associated graft-versus-host disease. Clin Diagn Lab Immunol 1994; 1: 590–596.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Petz LD, Calhoun L, Yam P et al. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and survey of predisposing factors. Transfusion 1993; 33: 742–750.

    Article  CAS  Google Scholar 

  5. Fischer A . Primary immunodeficiency diseases: an experimental model for molecular medicine. Lancet 2001; 357: 1863–1869.

    Article  CAS  Google Scholar 

  6. van Blokland WTM, Ignatiadis MG, Bosboom EC et al. An optimal microsatellite analysis for donor and recipient cells after bone marrow tranplantation. In: Charron D (ed.). Genetic Diversity of HLA, Functional and Medical Implication. EDK Press: Paris, France, 1997, pp 586–588.

    Google Scholar 

  7. Knobloch C, Goldman SF, Lattke H et al. Stable engraftment of allogeneic T lymphocytes in a patient with severe combined immunodeficiency following a transfusion with unirradiated blood. Transplantation 1991; 51: 818–824.

    Article  CAS  Google Scholar 

  8. Knobloch C, Dennert G . Loss of F1 hybrid resistance to bone marrow grafts after rejection of parental lymphocytes: demonstration of parental anti-F1 T killer cells and general immunosuppression in the host. Transplantation 1988; 45: 175–183.

    Article  CAS  Google Scholar 

  9. Roelen DL, Stobbe I, Young NT et al. Permissible and immunogenic HLA-A mismatches: cytotoxic T-cell precursor frequencies reflect graft survival data. Hum Immunol 2001; 62: 661–667.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Joyce van Loon, Petra van der Weide and Anette van Dijk for their excellent technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A van Royen-Kerkhof.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Royen-Kerkhof, A., Wulffraat, N., Kamphuis, S. et al. Nonlethal transfusion associated graft-versus-host disease in a severe combined immunodeficient patient. Bone Marrow Transplant 32, 1027–1030 (2003). https://doi.org/10.1038/sj.bmt.1704266

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704266

Keywords

Search

Quick links